Strumento inattivo

Azioni VBI Vaccines Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

VBI Vaccines : Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus	25/07/16
VBI Vaccines : Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer	25/07/16
VBI Vaccines : Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus	19/07/16
VBI Vaccines : Researchers Explore the Mechanisms by Which CMV Infection May Impact Fetal Brain Development	14/07/16
VBI Vaccines : Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate	13/07/16

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,66%	86,13 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 Mrd
BIOGEN INC.	-19,27%	30,42 Mrd
UCB	+57,86%	25,23 Mrd
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,35 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 Mrd
INCYTE CORPORATION	-17,69%	11,6 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 Mrd